PE20081701A1 - Derivados de pirrolopiridina-2-carboxamidas y su preparacion - Google Patents

Derivados de pirrolopiridina-2-carboxamidas y su preparacion

Info

Publication number
PE20081701A1
PE20081701A1 PE2008000152A PE2008000152A PE20081701A1 PE 20081701 A1 PE20081701 A1 PE 20081701A1 PE 2008000152 A PE2008000152 A PE 2008000152A PE 2008000152 A PE2008000152 A PE 2008000152A PE 20081701 A1 PE20081701 A1 PE 20081701A1
Authority
PE
Peru
Prior art keywords
methyl
pyrrolo
carboxamide
pyridin
pyridyl
Prior art date
Application number
PE2008000152A
Other languages
English (en)
Inventor
Laurent Dubois
Yannick Evanno
Andre Malanda
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PE20081701A1 publication Critical patent/PE20081701A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

REFERIDA A UN COMPUESTO DE PIRROLOPIRIDINA DE FORMULA (I), DONDE n ES UN ENTERO DE 0 A 3; X ES HALOGENO, ALQUILO C1-C6, CICLOALQUILO C3-C7, C(O)NR1R2, ENTRE OTROS; Y ES UN GRUPO HETEROARILO OPCIONALMENTE SUSTITUIDO CON CICLOALQUILO C3-C7, FLUOROALCOXILO C1-C6, NITRO, HIDROXILO, NR1R2, ENTRE OTROS; R1 Y R2 SON H, ALQUILO C1-C6, ARILALQUILENO C1-C5, ENTRE OTROS; W ES UN GRUPO BICICLICO CONDENSADO DE FORMULA (a), DONDE A ES UN HETEROCICLO DE 5 A 7 ESLABONES QUE COMPRENDE HETEROATOMOS TALES COMO O, N O S, OPCIONALMENTE SUSTITUIDO POR UNO O VARIOS H, ALQUILO C1-C6, FLUOROALQUILO C1-C6, OXO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-(2-METIL-BENZOTIAZOL-5-IL)-5-FLUORO-1[(4-PIRIDIL)METIL]-1H-PIRROLO[2,3-b]PIRIDIN-2-CARBOXAMIDA, N-(1,2-DIMETIL-1H-BENCIMIDAZOL-5-IL)-5-FLUORO-1-[(4-PIRIDIL)METIL]-1H-PIRROLO[2,3-b]PIRIDIN-2-CARBOXAMIDA, N-(2-METIL-BENZOTIAZOL-5-IL)-1-(3-PIRIDIL)-1H-PIRROLO[2,3-b]PIRIDIN-2-CARBOXAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DE LOS RECEPTORES TRPV1 (VR1) Y SON UTILES EN EL TRATAMIENTO DEL DOLOR, INFLAMACION, DOLOR NEUROPATICO, ENTRE OTROS
PE2008000152A 2007-01-19 2008-01-17 Derivados de pirrolopiridina-2-carboxamidas y su preparacion PE20081701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0700356A FR2911605B1 (fr) 2007-01-19 2007-01-19 Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
PE20081701A1 true PE20081701A1 (es) 2008-12-31

Family

ID=38457983

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000152A PE20081701A1 (es) 2007-01-19 2008-01-17 Derivados de pirrolopiridina-2-carboxamidas y su preparacion

Country Status (18)

Country Link
US (1) US8044066B2 (es)
EP (1) EP2106401B1 (es)
JP (1) JP5264772B2 (es)
AR (1) AR064936A1 (es)
AT (1) ATE549339T1 (es)
CL (1) CL2008000128A1 (es)
CY (1) CY1112855T1 (es)
DK (1) DK2106401T3 (es)
ES (1) ES2384289T3 (es)
FR (1) FR2911605B1 (es)
HR (1) HRP20120496T1 (es)
PE (1) PE20081701A1 (es)
PL (1) PL2106401T3 (es)
PT (1) PT2106401E (es)
SI (1) SI2106401T1 (es)
TW (1) TW200836726A (es)
UY (1) UY30875A1 (es)
WO (1) WO2008107543A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926554B1 (fr) 2008-01-22 2010-03-12 Sanofi Aventis Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
FR2926556B1 (fr) * 2008-01-22 2010-02-19 Sanofi Aventis Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
TWI501967B (zh) * 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
US20210253772A1 (en) 2020-02-18 2021-08-19 Covestro Llc Polyoxazolidinone compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049702A2 (en) 2001-12-10 2003-06-19 Amgen Inc. Vanilloid receptor ligands and their use in treatments
TW200403223A (en) 2002-02-15 2004-03-01 Glaxo Group Ltd Novel compounds
DE602004028122D1 (de) 2003-05-21 2010-08-26 Prosidion Ltd Pyrrolopyridin-2-carbonsäuren als hemmer der glycogenphosphorylase
US7544803B2 (en) * 2004-01-23 2009-06-09 Amgen Inc. Vanilloid receptor ligands and their use in treatments
GB0403819D0 (en) * 2004-02-20 2004-03-24 Merck Sharp & Dohme New compounds
US20090298745A1 (en) 2004-12-02 2009-12-03 Gerard Hugh Thomas Treatment of Diabetes with Glycogen Phosphorylase Inhibitors
JP2008530250A (ja) 2005-02-17 2008-08-07 メルク エンド カムパニー インコーポレーテッド アテローム性動脈硬化症、脂質代謝異常及び関連症状の治療方法
FR2888848B1 (fr) * 2005-07-22 2007-09-28 Sanofi Aventis Sa Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2888847B1 (fr) * 2005-07-22 2007-08-31 Sanofi Aventis Sa Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
FR2897061B1 (fr) * 2006-02-03 2010-09-03 Sanofi Aventis Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
CL2008000128A1 (es) 2008-05-23
FR2911605A1 (fr) 2008-07-25
US8044066B2 (en) 2011-10-25
AR064936A1 (es) 2009-05-06
PL2106401T3 (pl) 2012-08-31
EP2106401B1 (fr) 2012-03-14
JP2010516661A (ja) 2010-05-20
CY1112855T1 (el) 2016-02-10
HRP20120496T1 (hr) 2012-07-31
WO2008107543A2 (fr) 2008-09-12
EP2106401A2 (fr) 2009-10-07
ATE549339T1 (de) 2012-03-15
FR2911605B1 (fr) 2009-04-17
US20090298865A1 (en) 2009-12-03
TW200836726A (en) 2008-09-16
SI2106401T1 (sl) 2012-07-31
JP5264772B2 (ja) 2013-08-14
WO2008107543A3 (fr) 2008-12-24
ES2384289T3 (es) 2012-07-03
DK2106401T3 (da) 2012-07-02
UY30875A1 (es) 2008-09-02
PT2106401E (pt) 2012-06-18

Similar Documents

Publication Publication Date Title
PE20081549A1 (es) Derivados de n-(amino-heteroaril)-1h-pirrolopiridin-2-carboxamida y su preparacion
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
PE20140011A1 (es) Compuestos y composiciones novedosos para la inhibicion de nampt
PE20130230A1 (es) Derivados de carboxamidas n-azabiciclicas y su preparacion
CL2009000127A1 (es) Compuestos derivados de [indol, azaindol]-2-carboxamida sustituidos con un grupo silanilo; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso en el tratamiento del dolor, inflamacion, trastornos metabolicos, entre otras enfermedades mediadas por la modulacion del receptor trpv1.
PE20141358A1 (es) Polimorfos de inhibidores de cinasas
CO6470846A2 (es) Derivados aminobut´ricos sustituidos como inhibidores de neprilisina
UY31730A (es) Derivados polisustituidos de 6-heteroaril-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica.
PE20071325A1 (es) Derivados de n-heteroaril-carboxamidas triciclicas que contienen un resto bencimidazol, su preparacion y su aplicacion en terapeutica
PE20070112A1 (es) Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos
CL2009001152A1 (es) Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
DK1891038T3 (da) Substituerede n-arylpyrrolidiner som selektive androgenreceptormodulatorer
AR043015A1 (es) Compuestos moduladores de amida derivada de quinolina del receptor vanilloide vr1, composiciones farmaceuticas y veterinarias que los contienen y su uso en el tratamiento de enfermedades afectadas por la modulacion de dichos receptores
EA201171066A1 (ru) Новые замещенные производные бензоксазола, бензимидазола, оксазолопиридина и имидазопиридина в качестве модуляторов гамма-секретазы
AR073598A1 (es) Pirrolidinas 2-carboxamidas sustituidas, composiciones farmaceuticas que las contienen y uso de las mismas como agentes anticancer.
PE20201165A1 (es) Analogos de piridazina 1,4-disustituida y metodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
AR087328A1 (es) Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak
ATE457979T1 (de) Als androgen-rezeptor-modulatoren verwendbare tetrahydrocarbazol-derivate
UY31727A (es) Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica
UY31728A (es) Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica
UY29204A1 (es) Compuestos de imidazo(1,2-a)piridina, composiciones, usos y métodos relacionados
AR083831A1 (es) Antagonistas del receptor del cgrp de piperidinona carboxamida azaindano
ECSP099573A (es) Derivados heterocíclicos como receptores muscarínicos m3
CO6430439A2 (es) Agonistas del receptor de esfingosina -1- fosfato
AR046756A1 (es) Derivados de hidronopol como agonistas de receptores orl-1 humanos.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed